These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32629772)

  • 21. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
    Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A
    ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right Ventricular Dysfunction in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Hemodynamic Analysis of the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial and Registry.
    Lala A; Guo Y; Xu J; Esposito M; Morine K; Karas R; Katz SD; Hochman JS; Burkhoff D; Kapur NK
    J Card Fail; 2018 Mar; 24(3):148-156. PubMed ID: 29032225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
    Burkhardt BE; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009515. PubMed ID: 25806562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
    Prosperi-Porta G; Motazedian P; Di Santo P; Jung RG; Parlow S; Abdel-Razek O; Simard T; Hutson J; Malhotra N; Fu A; Ramirez FD; Froeschl M; Mathew R; Hibbert B;
    J Cardiol; 2022 Oct; 80(4):358-364. PubMed ID: 35725945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inotrope Use and Intensive Care Unit Mortality in Patients With Cardiogenic Shock: An Analysis of a Large Electronic Intensive Care Unit Database.
    Gao F; Zhang Y
    Front Cardiovasc Med; 2021; 8():696138. PubMed ID: 34621796
    [No Abstract]   [Full Text] [Related]  

  • 27. Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
    Jung RG; Di Santo P; Mathew R; Abdel-Razek O; Parlow S; Simard T; Marbach JA; Gillmore T; Mao B; Bernick J; Theriault-Lauzier P; Fu A; Lau L; Motazedian P; Russo JJ; Labinaz M; Hibbert B
    J Am Heart Assoc; 2021 Nov; 10(21):e021570. PubMed ID: 34713704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
    Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes.
    Sinha SS; Rosner CM; Tehrani BN; Maini A; Truesdell AG; Lee SB; Bagchi P; Cameron J; Damluji AA; Desai M; Desai SS; Epps KC; deFilippi C; Flanagan MC; Genovese L; Moukhachen H; Park JJ; Psotka MA; Raja A; Shah P; Sherwood MW; Singh R; Tang D; Young KD; Welch T; O'Connor CM; Batchelor WB
    Circ Heart Fail; 2022 Jun; 15(6):e009279. PubMed ID: 35510546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressors for acute myocardial infarction complicated by cardiogenic shock.
    Prondzinsky R; Hirsch K; Wachsmuth L; Buerke M; Unverzagt S
    Med Klin Intensivmed Notfmed; 2019 Feb; 114(1):21-29. PubMed ID: 29204662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology, monitoring, and treatment strategy in cardiogenic shock. A multinational cross-sectional survey of ESC-acute cardiovascular care association research section.
    Tavazzi G; Rossello X; Grand J; Gierlotka M; Sionis A; Ahrens I; Hassager C; Price S
    Eur Heart J Acute Cardiovasc Care; 2022 Sep; 11(9):706-711. PubMed ID: 35941730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
    Parlow S; Di Santo P; Mathew R; Jung RG; Simard T; Gillmore T; Mao B; Abdel-Razek O; Ramirez FD; Marbach JA; Dick A; Glover C; Russo JJ; Froeschl M; Labinaz M; Fernando SM; Hibbert B;
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):712-720. PubMed ID: 34382063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Temporary percutaneous ventricular assist devices for cardiogenic shock and high-risk percutaneous coronary intervention: a systematic literature review].
    Negro A; Pecoraro V; Camerlingo MD; Maltoni S
    G Ital Cardiol (Rome); 2020 Feb; 21(2):128-137. PubMed ID: 32051636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
    Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM
    Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome.
    Kaddoura R; Elbdri S
    Rev Cardiovasc Med; 2021 Sep; 22(3):691-715. PubMed ID: 34565070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-aortic balloon pump may grant no benefit to improve the mortality of patients with acute myocardial infarction in short and long term: an updated meta-analysis.
    Su D; Yan B; Guo L; Peng L; Wang X; Zeng L; Ong H; Wang G
    Medicine (Baltimore); 2015 May; 94(19):e876. PubMed ID: 25984680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current use of inotropes in circulatory shock.
    Scheeren TWL; Bakker J; Kaufmann T; Annane D; Asfar P; Boerma EC; Cecconi M; Chew MS; Cholley B; Cronhjort M; De Backer D; Dubin A; Dünser MW; Duranteau J; Gordon AC; Hajjar LA; Hamzaoui O; Hernandez G; Kanoore Edul V; Koster G; Landoni G; Leone M; Levy B; Martin C; Mebazaa A; Monnet X; Morelli A; Payen D; Pearse RM; Pinsky MR; Radermacher P; Reuter DA; Sakr Y; Sander M; Saugel B; Singer M; Squara P; Vieillard-Baron A; Vignon P; Vincent JL; van der Horst ICC; Vistisen ST; Teboul JL
    Ann Intensive Care; 2021 Jan; 11(1):21. PubMed ID: 33512597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levosimendan: a retrospective single-center case series.
    Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA
    J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.